# v4.14

## Related releases

## Data changes

### Gene

```
ANKRD26 Gene Summary Updated
ANKRD26 Gene Background Updated
ARHGAP26 Gene Summary Updated
ARHGAP26 Gene Background Updated
ATIC Gene Summary Updated
ATIC Gene Background Updated
CD70 Gene Summary Updated
CD70 Gene Background Updated
ERCC1 Gene Summary Updated
ERCC1 Gene Background Updated
FGF1 Gene Summary Updated
FGF1 Gene Background Updated
FGF2 Gene Summary Updated
FGF2 Gene Background Updated
FGF5 Gene Summary Updated
FGF5 Gene Background Updated
HFE Gene Summary Updated
HFE Gene Background Updated
HOXA11 Gene Summary Updated
HOXA11 Gene Background Updated
MN1 Gene Summary Updated
MN1 Gene Background Updated
PML Gene Summary Updated
PML Gene Background Updated
SRP72 Gene Summary Updated
SRP72 Gene Background Updated
TNFRSF17 Gene Summary Updated
TNFRSF17 Gene Background Updated
```

### Alteration

```
ABL1 E279K, Mutation Effect Description Updated
ABL1 M244V, Mutation Effect Description Updated
ABL1 L387M, Mutation Effect Description Updated
ABL1 L384M, Mutation Effect Description Updated
ABL1 L248V, Mutation Effect Description Updated
ABL1 G250R Added
ABL1 H396P, Mutation Effect Description Updated
ABL1 L248R, Mutation Effect Description Updated
ABL1 T315M Added
ABL1 V289A Added
ABL1 D287G Added
ABL1 M351T, Mutation Effect Updated
	 New: Likely Loss-of-function
	 Old: Likely Gain-of-function
ABL1 D363Y Added
ABL1 A365V Added
ABL1 I502L Added
ABL1 Q252H, Mutation Effect Description Updated
ABL1 V379I, Mutation Effect Description Updated
ABL1 E258D, Mutation Effect Description Updated
ABL1 Y253F, Mutation Effect Description Updated
ABL1 E275K, Mutation Effect Description Updated
ABL1 T277A, Mutation Effect Description Updated
ABL1 N336S Added
ABL1 Y342H Added
ABL1 M343T Added
ABL1 L364I Added
ABL1 A366G Added
ABL1 L387F Added
ABL1 Y393C Added
ABL1 A397P Added
ABL1 S417F Added
ABL1 I418S Added
ABL1 I418V Added
ABL1 S438C Added
ABL1 P441L Added
ABL1 E450K Added
ABL1 E450A Added
ABL1 E450G Added
ABL1 E450V Added
ABL1 E453V, Mutation Effect Description Updated
ABL1 P480L Added
ABL1 F486S Added
ABL1 G109D Added
ABL1 Y115N Added
ABL1 V289I Added
ABL1 A337T Added
ABL1 A337V Added
ABL1 E462K Added
ABL1 G463D Added
ABL1 G463S Added
ABL1 P465S Added
ABL1 V468F Added
ALK ATIC-ALK Fusion Added
ANKRD26 Gene Type Updated
ANKRD26 Amplification Added
ANKRD26 K1300N Added
ARHGAP26 Gene Type Updated
ATIC Gene Type Updated
ATIC Amplification Added
BRCA1 D522N Added
BRCA2 N289D Added
CD70 Gene Type Updated
CD70 Amplification Added
CIITA CIITA-PIERCE2 Fusion, Mutation Effect Description Updated
CIITA CIITA-PIERCE2 Fusion Name Changed
	 New: CIITA-PIERCE2 Fusion
	 Old: CIITA-BX648577 Fusion
EGFR C797S, Mutation Effect Description Updated
EGFR L747_T751delinsP, Mutation Effect Description Updated
EGFR Y891D, Oncogenicity Updated
	 New: Likely Neutral
	 Old: Resistance
EGFR F856V Added
ERBB2 L755P, Mutation Effect Description Updated
ERBB2 L755S, Mutation Effect Description Updated
ERCC1 Gene Type Updated
ERCC1 Deletion Added
ERCC1 Truncating Mutations Added
ERCC1 R156W Added
ERCC4 E875G, Oncogenicity Updated
	 New: Inconclusive
	 Old: Likely
FANCA S858R, Oncogenicity Updated
FGF1 Gene Type Updated
FGF1 Amplification Added
FGF2 Gene Type Updated
FGF2 Amplification Added
FGF5 Gene Type Updated
FGF5 Amplification Added
FGFR2 Oncogenic Mutations {excluding Fusions} Added
HFE Gene Type Updated
HOXA11 Gene Type Updated
HOXA11 Deletion Added
HOXA11 Truncating Mutations Added
KRAS G12C, Mutation Effect Description Updated
MET KIF5B-MET Fusion, Mutation Effect Description Updated
MET ST7-MET Fusion, Mutation Effect Description Updated
MET PRKAR2B-MET Fusion Added
MET CAPZA2-MET Fusion Added
MET PRKAR2B-MET Fusion, Mutation Effect Description Updated
MET CAPZA2-MET Fusion, Mutation Effect Description Updated
MN1 Gene Type Updated
MN1 Amplification Added
NFE2L2 E79Q, Mutation Effect Description Updated
NFE2L2 D29H, Mutation Effect Description Updated
NFE2L2 W24C, Mutation Effect Description Updated
NFE2L2 E79V Added
NFE2L2 Q26P Added
NFE2L2 Q26L Added
NFE2L2 Q26R Added
NFE2L2 D77G Added
NRAS D57A Added
NRG1 ATP1B1-NRG1 fusion, Mutation Effect Description Updated
NTRK1 R761W Added
NTRK1 BCAN-NTRK1 Fusion Added
NTRK1 ARHGEF2-NTRK1 Fusion Added
NTRK3 ETV6-NTRK3 Fusion, Mutation Effect Description Updated
NTRK3 I695V Added
NTRK3 G623E Added
PML Gene Type Updated
PML Truncating Mutations Added
PML Deletion Added
POLE A456P, Oncogenicity Updated
	 New: Likely
	 Old: Inconclusive
PTEN R130*, Mutation Effect Description Updated
PTEN R130* Deleted
RAF1 S259P, Mutation Effect Description Updated
SRP72 Gene Type Updated
TNFRSF17 Gene Type Updated
TNFRSF17 Amplification Added
```

### Evidence

```
FGFR2 Fusions, Bladder Cancer, Tumor Type Summary Updated
FGFR2 Fusions, Other Solid Tumor Types {excluding Bladder Cancer} Name Changed
	 New: Other Solid Tumor Types {excluding Bladder Cancer}
	 Old: Other Solid Tumor Types
FGFR2 Fusions, Bladder Cancer, Erdafitinib 1 Deleted
FGFR2 Oncogenic Mutations, All Solid Tumors {excluding Bladder Cancer} Name Changed
	 New: All Solid Tumors {excluding Bladder Cancer}
	 Old:
FGFR2 Oncogenic Mutations, All Solid Tumors {excluding Bladder Cancer, Cholangiocarcinoma} Name Changed
	 New: All Solid Tumors {excluding Bladder Cancer, Cholangiocarcinoma}
	 Old:  {excluding Cholangiocarcinoma}
FGFR2 Amplification, All Solid Tumors, RLY-4008  Updated
FGFR2 Fusions, Other Solid Tumor Types {excluding Bladder Cancer}, Tumor Type Summary Updated
FGFR2 Oncogenic Mutations {excluding Fusions}, Bladder Cancer, Tumor Type Summary Updated
FGFR3 FGFR3-TACC3 Fusion, FGFR3-BAIAP2L1 Fusion Added
FGFR3 Fusions, Bladder Cancer, Tumor Type Summary Updated
FGFR3 S371C, G380R, K650, Bladder Cancer, Tumor Type Summary Updated
FGFR3 R248C, S249C, G370C, Y373C, Bladder Cancer, Erdafitinib  Updated
FGFR3 Oncogenic Mutations, Bladder Cancer, Tumor Type Summary Updated
FGFR3 Oncogenic Mutations, Bladder Cancer, Erdafitinib 2 Added
FGFR3 S371C, G380R, K650, Bladder Cancer, Erdafitinib 3A Deleted
FGFR3 Fusions, Bladder Cancer, Erdafitinib 2 Deleted
FGFR3 FGFR3-TACC3 Fusion, FGFR3-BAIAP2L1 Fusion, Bladder Cancer, Tumor Type Summary Updated
FGFR3 FGFR3-TACC3 Fusion, FGFR3-BAIAP2L1 Fusion, Other Solid Tumor Types Added
IDH1 R132C, R132H, R132G, R132S, R132L, Acute Myeloid Leukemia, Ivosidenib  Updated
KRAS G12C, Non-Small Cell Lung Cancer, Sotorasib  Updated
KRAS G12C, Colorectal Cancer, Adagrasib + Cetuximab, Adagrasib + Panitumumab, Sotorasib + Cetuximab, Sotorasib + Panitumumab  Updated
MDM2 Amplification, Well-Differentiated Liposarcoma Name Changed
	 New: Well-Differentiated Liposarcoma
	 Old: Dedifferentiated Liposarcoma, Well-Differentiated Liposarcoma
MDM2 Amplification, Well-Differentiated Liposarcoma, Tumor Type Summary Updated
MDM2 Amplification, Dedifferentiated Liposarcoma Added
MDM2 Amplification, Intimal Sarcoma Added
MDM2 Amplification, Well-Differentiated Liposarcoma, Brigimadlin 3A Added
MDM2 Amplification, Dedifferentiated Liposarcoma, Tumor Type Summary Updated
MDM2 Amplification, Other Solid Tumor Types Added
MDM2 Amplification, Other Solid Tumor Types, Tumor Type Summary Updated
NTRK1 Fusions, All Solid Tumors, Entrectinib  Updated
NTRK2 Fusions, All Solid Tumors, Entrectinib  Updated
NTRK3 Fusions, All Solid Tumors, Entrectinib  Updated
```
